Introduction
============

Chronic rhinosinusitis (CRS) is a clinical disorder that encompasses a heterogeneous group of infections and inflammatory conditions affecting the nose and the paranasal sinuses. [@BR0745or-1] [@JR0745or-2] [@JR0745or-3] Chronic rhinosinusitis is a common disease in otorhinolaryngologic practice worldwide. [@JR0745or-2] Antibiotics are prescribed empirically, which could result in treatment failure and in the development of antimicrobial resistance. [@JR0745or-4] [@JR0745or-5]

In 1996, the multidisciplinary Rhinosinusitis Task Force of the American Academy of Otolaryngologists, Head and Neck Surgeons (AAO-HNS) [@JR0745or-6] proposed a clinical diagnosis of CRS as a continuous inflammation of the mucosa of the nose and of the paranasal sinuses with at least 2 major and 1 minor criteria or 2 minor and 1 major criteria for at least 12 consecutive weeks. [@JR0745or-7] The major criteria include nasal obstruction/blockage, nasal discharge/purulence/discolored postnasal drainage, hyposmia/anosmia, facial pain/pressure, and purulence in the nasal cavity on examination. The minor criteria are headache, fever, halitosis, dental pain, cough and ear pain/pressure/fullness.

The Sinus and Allergy Health Partnership (SAHP) [@JR0745or-8] upheld the proposal of the AAO-HNS and put forward that objective evidence of inflammation must be present and identified in association with the ongoing symptoms. Hence, a nasal endoscopy and a computed tomography (CT) scan of the paranasal sinuses or a plain occipitomental (OM) view sinus radiograph should be necessary as means of supporting the diagnosis of adult CRS.

Bacteria, fungi or viruses may be involved in many cases, but there may be some cases with no identifiable pathogenic organism. Generally, pathogen-positive cultures are recovered in 50 to 60% of the patients with CRS. [@JR0745or-9] [@JR0745or-10] In Nigeria, while a study in Ilorin [@JR0745or-4] showed that 45% of the patients with CRS had pathogenic isolates using a posterior nasal swab, another study in Sokoto [@JR0745or-5] showed that infective causes accounted for 67.1% of the cases of CRS. The study from Ilorin [@JR0745or-4] showed sensitivity to ofloxacin, cefuroxime and resistance to penicillins. Amoxicillin-clavulanate was also shown to be effective in CRS.

Antibiotics are by far the most commonly prescribed drugs for CRS. [@BR0745or-1] [@JR0745or-11] The selection of these antibiotics is usually empirical, sometimes with inadequate dose and duration of treatment. To treat patients adequately and to prevent the development of resistance, it is necessary to prescribe the appropriate antimicrobial for the appropriate duration based on the antibiotic sensitivity of the pathogens involved. Therefore, the identification of these pathogens should form the basis of prescribing antibiotics. The present study aims to determine the antibiotic sensitivity pattern in patients with CRS seen at the study center.

Methods
=======

This was a prospective cross-sectional descriptive study aimed at determining the sensitivity pattern of bacterial isolates associated with CRS among patients suffering from this condition. The research was conducted at the study center in the the National Ear Care Centre from samples collected by endoscopically-guided middle meatal swabs (Karl Storz, Germany). Ethical clearance was obtained from the institutional Health Research Ethics Committee (HREC). Middle meatal swabs from 130 patients with CRS were analyzed microbiologically to determine the common pathogens. The study population included male and female patients attending the clinic of the study center who met the diagnostic criteria of CRS according to the multidisciplinary Rhinosinusitis Task Force of the AAO-HNS [@JR0745or-6] as modified by the Sinus and Allergy Health Partnership (SAHP). [@JR0745or-8] A plain OM view sinus radiograph of the paranasal sinuses was used for supporting the diagnosis of CRS. Consecutive patients seen by the researchers in the study center with diagnosis of CRS from November 2013 to May 2014 who satisfied the inclusion criteria were recruited.

A structured questionnaire based on the research questions was employed for the present study. A DARAY HL 550 medical examination headlight (Daray Ltd., Derbyshire, UK) served as the light source for the physical examination. A Thudicum nasal speculum was used for anterior rhinoscopy; rigid endoscopes in sizes 2.7 mm and 4 mm, 0° and 30° were used for nasal endoscopy, and an endoscopically-guided middle meatal swab was used for the collection of samples. Local anesthesia, vasoconstriction, and decongestion were achieved with 10% xylocaine spray and 2% lignocaine in adrenalin at 1:200,000 dilution.

A 10-milliliters syringe filled with normal saline solution was then used to irrigate the nasal cavities, and then a sterile swab stick was used to take the swab from the middle meatus. The collected swab was inoculated on to the culture media: Chocolate agar and macConkey agar for aerobic cultures; cooked meat agar and blood agar for anaerobic cultures.

An oxygen absorbing and carbon-dioxide generating Master Anaerobic GasPak (Micromaster Laboratories PVT, Maharashtra, India) was used for anaerobic culture, while an Equitron anaerobic jar (Equitron Medica Private Limited, Mumbai, India) was used for the incubation and the rearing of anaerobes.

The antibiotic sensitivity test was performed by the diffusion method [@BR0745or-12] using a Multidisk maxidisc high profile +ve (Maxicare medical laboratory, Nigeria), including Peflacine (10 µg), gentamycin (10 µg), Ampiclox (30 µg), Zinacef (20 µg), Rocephin (25 µg), ciprofloxacin (10 µg), streptomycin (30 µg), Septrin (30 µg), erythromycin (10 µg), and negative including Septrin (30 µg), chloramphenicol (30 µg), sparfloxacin (10 µg), ciprofloxacin (10 µg), amoxicillin (30 µg), gentamycin (10 µg), pefloxacin (30 µg), Tarivid (10 µg) and streptomycin (30 µg). Other single-disc antibiotic-sensitivity tests included metronidazole and Augmentin. The reading was based on the zone of inhibition measured in millimeters using a calibrated ruler, using an interpretative chart of zone sizes according to the antibiotics, and were graded as sensitive (++ + ), intermediate (++), or resistant.

Results
=======

A total of 130 patients with CRS were studied. The age range was between 18 and 55 years old, with a mean age of 31.87 ± 8.60 years old. The sample consisted of 67 (51.5%) males and 63 (48.5%) females, with a male to female ratio of 1.1:1, as shown in [Table 1](#TB0745or-1){ref-type="table"} .

###### Age and gender distribution of study group

  Group age (years)   Gender       Total        
  ------------------- ------------ ------------ ------------
  11--20              4            13           17
  21--30              34           17           51
  31--40              19           25           44
  41--50              8            8            16
  51--60              2            −            2
  Total               67 (51.5%)   63 (48.5%)   130 (100%)

The history of empirical treatment of the CRS patients with antibiotics in the last 6 months prior to the ear, nose, and throat (ENT) consultation is shown in [Table 2](#TB0745or-2){ref-type="table"} . About 57% of the patients admitted to the use of antibiotics (mostly Ampiclox and amoxicillin) before the ENT consultation, as shown in [Table 2](#TB0745or-2){ref-type="table"}

###### History of antibiotic usage for chronic rhinosinusitis by the patients studied

  Types of Antibiotic    Frequency   Percentage (%)
  ---------------------- ----------- ----------------
  Ampiclox               28          21.5
  Amoxicilin             23          17.7
  Augmentin              11          8.5
  Metronidazole          5           3.8
  Ciprofloxacin          4           3.1
  Cefuroxime             3           2.3
  Total                  74          56.9
  \*\*\*Missing System   56          43.1
  Total                  130         100.0

\*\*\* Those without empirical treatment with antibiotics in the last 6 months prior to the otolaryngology consultation.

[Table 3](#TB0745or-3){ref-type="table"} shows the distribution of various bacterial isolates. There were 74 (56.92%) positive bacterial growths among the 130 subjects, out of which 55 (74.32%) were aerobic and 19 (25.68%) were anaerobic. About 18% of these positive bacterial growths yielded a mixed growth of aerobic and anaerobic isolates. The most common bacterial isolates were *Staphylococcus aureus* (35.14%), *Haemophilus influenzae* (12.16%), *Streptococcus viridians* (10.81%) and *Streptococcus pneumonia* 5 (6.76%).

###### Distribution of various isolates in participants

  Species                                Swab specimen of patients
  -------------------------------------- ---------------------------
  Bacterial isolates                     ( *n*  = 74)
  ***Aerobic bacterial isolates***       
  ***Gram positive***                    
  * Staphylococcus aureus*               26 (35.14%)
  * Coagulase negative staphylococcus*   4 (5.41%)
  * Streptococcus viridans*              8 (10.81%)
  * Streptococcus pneumonia*             5 (6.76%)
  ***Gram negative***                    
  * Haemophilus influenzae*              9 (12.16%)
  * Pseudomonas aeruginosa*              1 (1.35%)
  * Neisseria specie*                    2 (2.70%)
  Total aerobic bacteria                 55 (74.32%)
  ***Anaerobic bacterial isolates***     
  ***Gram positive***                    
  * Peptostreptococcus*                  8 (10.81%)
   Anaerobic bacillus                    5(6.76%)
  ***Gram negative***                    
  * Bacteroides spp*                     6 (8.11%)
   Total anaerobic bacterial isolates    19 (25.68%)
  Total bacterial isolates               74 (100%)

[Tables 4](#TB0745or-4){ref-type="table"} and [5](#TB0745or-5){ref-type="table"} show the antibiotic sensitivity pattern of the studied bacterial isolates. Augmentin, ciprofloxacin, and Peflacine were found to be the most effective, with 100% sensitivity, followed by levofloxacin, Rocephin, erythromycin, and Zinat, in that order, showing intermediate sensitivity. Most isolates were resistant to Ampiclox, Amoxil and Septrin.

###### Sensitivity pattern of bacterial isolates in chronic rhinosinusitis

  Isolates tested             Freq   Au    Cp    Pef   E             R             Z
  --------------------------- ------ ----- ----- ----- ------------- ------------- -------------
  *Staphylococcus aureus*     27     27s   27s   27s   15s,12i       20s,7i        15s,12i
  CONS                        27     27s   27s   27s   12s,15i       22s, 5i       16s,11i
  *Streptococcus viridians*   8      8s    8s    8s    7i, 1s        6s, 2i        5s,3i
  *Streptococcus pneumonia*   5      5s    5s    5s    5s            4s,1i         5s
  *Haemophilus influenzae*    9      9s    9s    9s    9s            9s            9i
  *Pseudomonas aeruginosa*    1      1s    1s    1s    1r            1r            1r
  *Neisseria specie*          3      3s    3s    3s    3s            3s            3s
  *Peptostreptococcus*        8      8s    8s    8s    8r            8r            8r
  Anaerobic bacillus          5      5s    5s    5s    5r            5r            5r
  *Bacteroides spp*           6      6s    6s    6s    6r            6r            6r
  **Total**                   99     99s   99s   99s   45s,34i,20r   64s,15i,20r   44s,35i,20r

Abbreviations: Au, Augmentin; CONS, coagulase negative staphylococcus species; Cp, ciprofloxacin; E, erythromycin; i, intermediate sensitivity; Pef, Peflacine; r, resistant; R, Rocephin; s, sensitive; Z, Zinat.

###### Sensitivity pattern of bacterial isolates in chronic rhinosinusitis

  Isolates tested             Freq   Ax         Am             S               M              L
  --------------------------- ------ ---------- -------------- --------------- -------------- ----------
  *Staphylococcus aureus*     27     10i,17r    27i            10s,17i         27i            21s,6i
  CONS                        27     7i, 20r    20i, 7r        6s,21i          27i            23s, 4i
  *Streptococcus viridians*   8      4i, 4r     8i             8i              6i,2r          6s, 2i
  *Streptococcus pneumonia*   5      3i, 2r     4i,1r          5i              5i             4s, 1s
  *Haemophilus influenzae*    9      2i, 7r     7i, 2r         4i,5r           9i             7s, 2i
  *Pseudomonas aeruginosa*    1      1r         1r             1r              1s             1i
  *Neisseria specie*          3      1i, 2r     3s             3i              3i             2s,1i
  *Peptostreptococcus*        8      8r         8r             8r              8s             6s, 2i
  *Anaerobic bacillus*        5      5r         5r             5r              5s             3s, 2i
  *Bacteroides spp*           6      6r         6r             6r              6s             3s, 3i
  **Total**                   99     27i, 72r   3s, 66i, 30r   16s, 58i, 25r   20s, 77i, 2r   75s, 24i

Abbreviations: Am, Amoxil; Ax, Ampiclox; CONS, coagulase negative staphylococcus species; i, intermediate sensitivity; L, levofloxacin; M, metronidazole; r, resistant; s, sensitive; S, Septrin.

Discussion
==========

Culture targeted therapy based on the antibiotic sensitivity of the pathogens identified in patients with CRS remains the gold standard if cure is the primary aim of the treatment.

In the present study, there were 74 (56.92%) bacterial growths, of which 55 (74.32%) were aerobic, and 19 (25.68%) were anaerobic. This falls within the global average rate of between 50 and 60% in the recovery of bacterial growth in CRS. [@JR0745or-9] [@JR0745or-10] However, this is higher than the findings of Ologe et al in Ilorin, who reported a prevalence of 45% of bacterial growth in patients with CRS. [@JR0745or-4] The difference could be either because only aerobic bacteria were evaluated in that study or due to a difference in the geopolitical area.

The most common bacterial isolates were *S. aureus* (35.14%), *H. influenzae* (12.16%), *S. viridians* (10.81%) and *S. pneumonia* 5 (6.76%). These findings are similar to those reported in the study by Araujo et al, [@JR0745or-13] in Brazil, in which *S. aureus* (31%) was the most common aerobe found. However, it is lower than the prevalence of 48.1% reported by Ologe et al, [@JR0745or-4] who used swabs from the posterior nasal fossa instead of the middle meatal swab used in the present study.

In the present study, Augmentin, ciprofloxacin and Peflacine were found to be most effective. Rocephin, levofloxacin, erythromycin and Zinat were effective but not as effective as the first three. This suggests that levofloxacin may not be as effective as other quinolones in the treatment of CRS. Therefore, there is a need for further studies to verify its efficacy in CRS. In the present study, Zinat showed intermediate sensitivity to most isolates. There was resistance to Ampiclox, Amoxil and Septrin. The penicillins were similarly found to be least sensitive in a study by Ologe et al [@JR0745or-4] in Ilorin, where ofloxacin had 100% sensitivity. Kamau et al [@JR0745or-14] reported that erythromycin, cefadroxil, chloramphenicol and amoxicillin have high sensitivity, while ampicillin, cotrimoxazole, and pefloxacin had poor sensitivity in Kenya, showing both comparable and contrasting features with the present study. This may be due to a difference in the antibiotic resistance pattern in different geographical regions in the country. The fact that the isolates in the present study are less susceptible to cephalosporins than to ciprofloxacin, Peflacin and Augmentin may be due to the anaerobes and gram-negative aerobes, but cross-resistance with penicillins might be a possibility. This resistance is of public health importance because the history of antibiotic usage by the patients revealed that ∼ 40% of the patients with CRS used either Ampiclox or Amoxil prior to the ENT consultation in the present study.

Conclusion
==========

In the present study, Augmentin, ciprofloxacin and Peflacine have 100% sensitivity, while most of the organisms show resistance to Ampiclox, amoxicillin and Septrin.
